Pfeffer Sandra, Gmeiner Günter, Gärtner Peter
Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria.
Institute of Applied Synthetic Chemistry, TU Wien, Vienna, Austria.
Drug Test Anal. 2022 Nov;14(11-12):1871-1876. doi: 10.1002/dta.3234. Epub 2022 Feb 21.
The urinary steroid profile established for the monitoring of eventual testosterone or testosterone precursor application by athletes includes concentrations and ratios of various endogenously produced steroidal hormones and metabolites. Due to enzymatic activities in urine specimens, the concentrations of these endogenous steroids and consequently their ratios may alter, leading to potential misinterpretation of analytical results. Microbiological contamination in athletes' urine samples can occur due to urinary tract infections or due to contamination by the non-sterile sample collection conditions. Depending on the duration of transportation of urine samples, the transport and storage conditions may favour microorganisms' growth, and therefore, the enzymatic activity can be accelerated. Degradation effects on endogenous steroids caused by microorganisms have been observed, such as hydrolysis of steroid conjugates, increase of testosterone in the free fraction or modification of the steroid structure by oxidoreductive reactions. The World Anti-Doping Agency (WADA) implemented criteria to check for signs of microbial degradation in a technical document dealing with the detection, analysis and reporting of endogenous androgenic anabolic steroids (TD EAAS) in urine samples. During the endogenous steroid profile confirmation procedures (CPs) of the WADA accredited Seibersdorf Laboratory, significant differences in the concentrations of markers of the steroid profile were observed compared to the initial testing procedures (ITPs). The changes in concentrations of the urinary steroid profile were attributed to the reduction of the 17-keto group to a 17β-hydroxy group caused by increased enzymatic activity during the hydrolysis step. In order to monitor the 17-keto reduction activity in athletes' urine specimens, possible marker substances containing a 17-keto group were synthesised and added in the internal standards mixture (ISTD) of the ITP. The presence of the reduced 17β-hydroxy form of the marker substance indicated enzymatic activity leading to 17-keto reduction reactions. The substance 3β-ethoxy-5α-androstane-17-one was defined to be suitable to indicate 17-keto reduction reactions occurring during hydrolysis carried out at moderate temperatures.
为监测运动员最终是否使用睾酮或睾酮前体而建立的尿液类固醇谱,包括各种内源性产生的甾体激素和代谢物的浓度及比例。由于尿液标本中的酶活性,这些内源性类固醇的浓度及其比例可能会发生变化,从而导致分析结果出现潜在的误判。运动员尿液样本中的微生物污染可能源于尿路感染,也可能是由于非无菌样本采集条件造成的污染。根据尿液样本的运输时长,运输和储存条件可能有利于微生物生长,进而加速酶活性。已观察到微生物对内源性类固醇的降解作用,例如类固醇结合物的水解、游离部分睾酮的增加或通过氧化还原反应对类固醇结构的修饰。世界反兴奋剂机构(WADA)在一份关于尿液样本中内源性雄激素同化类固醇(TD EAAS)检测、分析和报告的技术文件中实施了检查微生物降解迹象的标准。在WADA认可的赛伯斯多夫实验室进行的内源性类固醇谱确认程序(CPs)中,与初始检测程序(ITPs)相比,观察到类固醇谱标记物浓度存在显著差异。尿液类固醇谱浓度的变化归因于水解步骤中酶活性增加导致17 - 酮基还原为17β - 羟基。为了监测运动员尿液标本中的17 - 酮基还原活性,合成了可能含有17 - 酮基的标记物质并添加到ITP的内标混合物(ISTD)中。标记物质还原后的17β - 羟基形式的存在表明发生了导致17 - 酮基还原反应的酶活性。物质3β - 乙氧基 - 5α - 雄甾烷 - 17 - 酮被定义为适合指示在适度温度下水解过程中发生的17 - 酮基还原反应。